Chronic Total Occlusion Devices: Market Insights
The chronic total occlusion devices market is projected to grow at a high CAGR over the coming years on account of increasing demand for treating cardiovascular disease. Chronic total occlusion (CTO) is prevalent in about one-third of patients who undergo angiography. It is expected that the number of bypass surgeries are expected to reduce if surgeons focus on improving their ability to treat CTO.
The growing demand for interventional cardiology devices is also projected to positively influence market growth. Coronary artery disease (CAD) is one of the most common. The increasing number of patients with coronary artery disease (CAD) and peripheral artery disease (PAD) is projected to augment the use of CTO treatment across the world.
Chronic Total Occlusion Devices Market: Equipment and End-Use Segmentation
On the basis of equipment, the chronic total occlusion devices market is segmented into Microcatheters, Guidewires, Crossing Devices, and Re-Entry Devices among others. The chronic total occlusion devices market has been segmented into Hospitals & Diagnostic Centers, Ambulatory Care Centers (ACC), Others; on the basis on end-use.
Chronic Total Occlusion Devices Market: Regional Insights
The demand for chronic total occlusion devices is expected to grow at a high CAGR in North America, Europe and Asia Pacific. Training initiatives taken up by manufactures & associations is expected to benefit physicians in understanding the techniques and technology used in CTO procedure.
Technological developments and improvement in techniques has increased the success rate of CTO percutaneous coronary intervention. Approximately 20% of patients diagnosed with coronary disease on angiography have chronic total occlusion. Increasing investments in healthcare infrastructure in Asia Pacific is expected to positively influence market growth over the coming years. In May 2017, a European randomized trial was conducted to compare PCI with optimized medical therapy. This study revealed high success rate and low procedural risk with PCI, which is expected to increase the preference for CTO devices over the coming years.
Chronic Total Occlusion Devices Market: Vendor Landscape
The report contains a chapter dedicated to vendors operating in the chronic total occlusion devices market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.
Chronic Total Occlusion Devices Market: End-Use Landscape
The report provides a detailed list of end-users operating across the world. The end-user landscape includes consumer contact details, geographical presence, revenue, product portfolio, organic and inorganic growth strategies among others. Some of the companies who are likely to use chronic total occlusion devices include Wellspan York Hospital, Beth Israel Deaconess Medical Center, and NewYork–Presbyterian Hospital among others.
Chronic Total Occlusion Devices Market: Market Share & Competitor Analysis
Some of the major companies engaged in the chronic total occlusion devices market are Medtronic, Boston Scientific Corporation, Terumo Europe, Cordis Corporation, Spectranetics, IntraLuminal Therapeutics, Bard Peripheral Vascular, Baylis Medical Company, Inc., and Soundbite Medical Solutions among others. The market is expected to witness launch of new products and increased investments for research & training.
In June 2015, Cordis Corporation launched ELITECROSS Support Catheter in the U.S. and OUTBACK Elite Re-Entry Catheter in the U.S., Europe, and Japan. The products are designed to support physicians in treating complex lesions using interventional techniques. The development of new and improved products is expected to increase the success rate of CTO treatment over the coming years.
Avail customized purchase options to meet your exact research needs: